Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference

BMC Cardiovascular Disorders

Research Article

Brian W Whitcomb¹  Braxton D Mitchell²  Keith Tanner²  Patrick F McArdle²  Alan R Shuldiner³  Afshin Parsa⁴ 

[1] Division of Biostatistics and Epidemiology, School of Public Health and Health Science, University of Massachusetts, Amherst, MA, USA;Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine, 660 West Redwood Street, Rm. 492, 21201, Baltimore, MD, USA;Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine, 660 West Redwood Street, Rm. 492, 21201, Baltimore, MD, USA;Geriatric Research and Education Clinical Center, Veterans Administration Medical Center, Baltimore, MD, USA;Division of Nephrology, University of Maryland School of Medicine, Baltimore, MD, USA;

关键词: Bilirubin;    Mendelian randomization;    Cardiovascular disease;   

DOI  :  10.1186/1471-2261-12-16

 received in 2011-09-13, accepted in 2012-03-14,  发布年份 2012

来源: Springer

【 摘 要 】

BackgroundElevated serum bilirubin has been associated with reduced risk of cardiovascular disease (CVD). However, serum bilirubin is also related with several potential confounders related to CVD, such as obesity. Mendelian randomization has been proposed as a method to address challenges to validity from confounding and reverse causality. It utilizes genotype to estimate causal relationships between a gene product and physiological outcomes. In this report, we demonstrate its use in assessing direct causal relations between serum bilirubin levels and CVD risk factors, including obesity, cholesterol, measures of vascular function and blood pressure.MethodsStudy subjects included 868 asymptomatic individuals. Study subjects were genotyped at the UGT1A1*28 locus, which is strongly associated with bilirubin levels.ResultsSerum bilirubin levels were inversely associated with levels of several cardiovascular disease risk factors, including body mass index (p = 0.003), LDL (p = 0.0005) and total cholesterol (p = 0.0002). In contrast, UGT1A1*28 genotype, a known cause of elevated bilirubin levels, was not significantly associated with any of these traditional CVD risk factors. We did observe an association between genotype and brachial artery diameter (p = 0.003) and cold pressor reactivity (p = 0.01).ConclusionsOur findings imply that the observed association of serum bilirubin levels with body mass index and cholesterol are likely due to confounding and suggest that previously established CVD benefits of increased bilirubin may in part be mediated by the early regulation of vascular structure and reactivity.

【 授权许可】

CC BY   
© McArdle et al; licensee BioMed Central Ltd. 2012